المستودع الأكاديمي جامعة المدينة

Treatment of Kala-azar in Southern Sudan Using a 17-day Regimen of Sodium Stibogluconate Combined with Paromomycin: A Retrospective Comparison with 30-day Sodium Stibogluconate Monotherapy.

أعرض تسجيلة المادة بشكل مبسط

dc.contributor Médecins sans Frontières-Holland, Amsterdam, The Netherlands.
dc.creator Melaku, Y
dc.creator Collin, S
dc.creator Keus, K
dc.creator Gatluak, F
dc.creator Ritmeijer, K
dc.creator Davidson, R N
dc.date 2007-07
dc.date.accessioned 2017-01-31T07:10:40Z
dc.date.available 2017-01-31T07:10:40Z
dc.identifier Treatment of Kala-azar in Southern Sudan Using a 17-day Regimen of Sodium Stibogluconate Combined with Paromomycin: A Retrospective Comparison with 30-day Sodium Stibogluconate Monotherapy. 2007, 77 (1):89-94 Am. J. Trop. Med. Hyg.
dc.identifier 0002-9637
dc.identifier 17620635
dc.identifier http://hdl.handle.net/10144/22936
dc.identifier http://fieldresearch.msf.org/msf/handle/10144/22936
dc.identifier The American Journal of Tropical Medicine and Hygiene
dc.identifier.uri http://dspace.mediu.edu.my:8181/xmlui/handle/10144/22936
dc.description Médecins sans Frontières-Holland has treated > 67,000 patients with kala-azar (KA) in southern Sudan since 1989. In 2002, we replaced the standard regimen of 30 days of daily sodium stibogluconate (SSG) with a 17-day regimen of daily SSG combined with paromomycin (PM). We analyzed data for 4,263 primary KA patients treated between 2002 and 2005 in southern Sudan to determine the relative efficacy of the combination therapy regimen (PM/SSG). The initial cure rate among patients treated with PM/SSG was 97.0% compared with 92.4% among patients treated with SSG monotherapy. Relative efficacy of PM/SSG compared with SSG increased over the study period: odds of death in the PM/SSG group were 44% lower (odds ratio [OR] = 0.56, 95% confidence interval [CI] = 0.37-0.84) in 2002, 78% lower (OR = 0.22, 95% CI = 0.10-0.50) in 2003, and 86% lower (OR = 0.14, 95% CI = 0.07-0.27) in 2004-2005. In remote field settings, 17 days of SSG combined with PM gives better survival and initial cure rates than 30 days of SSG monotherapy.
dc.language en
dc.publisher American Society of Tropical Medicine and Hygiene
dc.relation http://www.ajtmh.org
dc.rights Archived on this site with the kind permission of the American Society of Tropical Medicine and Hygiene, http://www.astmh.org
dc.title Treatment of Kala-azar in Southern Sudan Using a 17-day Regimen of Sodium Stibogluconate Combined with Paromomycin: A Retrospective Comparison with 30-day Sodium Stibogluconate Monotherapy.


الملفات في هذه المادة

الملفات الحجم الصيغة عرض

لا توجد أي ملفات مرتبطة بهذه المادة.

هذه المادة تبدو في المجموعات التالية:

أعرض تسجيلة المادة بشكل مبسط